您的购物车当前为空
Tuvonralimab (PSB-205; QL1706) 是一种双重免疫检查点阻断剂,包含有抗 PD-1IgG4和抗 CTLA-4IgG1 抗体、Iparomlimab 和 Tuvonralimab。
Tuvonralimab (PSB-205; QL1706) 是一种双重免疫检查点阻断剂,包含有抗 PD-1IgG4和抗 CTLA-4IgG1 抗体、Iparomlimab 和 Tuvonralimab。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,900 | 2-4周 | |
| 5 mg | ¥ 7,470 | 2-4周 | |
| 10 mg | ¥ 12,000 | 2-4周 |
Tuvonralimab 相关产品
| 产品描述 | Tuvonralimab (PSB-205; QL1706), comprising a combination of Iparomlimab and Tuvonralimab [1], functions as a dual immune checkpoint inhibitor through its formulation of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies. |
| CAS No. | 2417649-44-4 |
| 存储 | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容